Vice President, Head of Quality
Todd is the Head of Quality at Unum with more than 20 years of experience in various quality roles in biotech. Prior to joining Unum, Todd served as Head of Quality for Neon Therapeutics, where he established phase appropriate quality systems for managing Phase 1 clinical trials and drug product release of immunotherapy personalized vaccines and autologous T cell therapies treating various types of cancer. Prior to joining Neon, Todd was Head of Quality for Akebia Therapeutics where he worked with clinical, regulatory, and CMC operations to provide quality oversight of a global Phase 3 clinical trial for a new class of drug to treat anemia due to chronic kidney disease. Prior to Akebia, Todd gained commercial quality experience at Genzyme/Sanofi where he was involved in several drug product launches for therapies treating rare diseases and provided oversight for the remediation plan to bring the Genzyme Allston facility into compliance under a consent decree, resulting in a successful certification by the FDA. Todd received a Bachelor of Science in Biology from Saint Michael’s College. He enjoys skiing, golf, playing basketball with his three sons and craft beer. He has enjoyed watching the expansion of good breweries in the northeast.